Home > Investor Information > Overview
Main contents starts here
Overview
Takeda aims to become a company that grows together with its shareholders and other stakeholders while developing a strong identity as a good corporate citizen. Takeda has committed to strengthening information disclosure activities. Takeda is proactively striving for information disclosure, based on the Company policy targeting management transparency.
IR News
- March 5, 2010
KAPIDEX™ (dexlansoprazole) Renamed DEXILANT™ in U.S. to Avoid Name Confusion - March 3, 2010
Lundbeck and Takeda finalise plans to initiate phase III pivotal clinical trials with Lu AA21004 and Lu AA24530 - February 23, 2010
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity - February 18, 2010
HEMATIDE™ ENTERED INTO THE PHASE 3 CLINICAL PROGRAM TO TREAT ANEMIA IN CHRONIC RENAL FAILURE PATIENTS IN JAPAN
Latest Financial Results
FY 2009 Q3 Results
( February 3, 2010 )
 |
|
|
-
- →link to Nomura IR's website
Latest Reports
2009 Annual Report
|
|
2009 CSR Databook
|
|
IR Calendar
- February 3, 2010
3rd Quarter of FY2009 financial results announcement & conference call - Early May, 2010
FY2009 financial results announcement - Early May, 2010
Media/Analysts/Institutional investors meeting on results for FY2009 (at the Tokyo Office) - Early June, 2010
Convocation notice of the Ordinary General Meeting of Shareholders - Late June, 2010
Ordinary General Meeting of Shareholders - Late June, 2010
Resolutions notice of the Ordinary General Meeting of Shareholders - Late June, 2010
Commencement date for dividend payment (For the year ended March 31, 2010) - Late July, 2010
1st Quarter of FY2010 financial results announcement & conference call - November, 2010
Annual Report 2010 (For the year ended March 31, 2011) - Early November, 2010
2nd Quarter of FY2010 financial results announcement - Early November, 2010
Media/Analysts/Institutional investors meeting on results for the 2nd Quarter of FY2010 (at the Tokyo Office) - Early December, 2010
Commencement date for payment of interim dividend (For the year ended March 31, 2011)
Note : that the dates shown above are tentative plans and subject to change.
Stock Performance
TSE 3/12 10:09
- Last
- 4,140
- Change
- +65